Top Markets
#1 Zora Zora +31.42%
#2 SSV Network SSV Network +23.75%
#3 Arowana Arowana +23.56%
#4 Pieverse Pieverse +23.14%
#5 Fabric Protocol Fabric Protocol +22.66%
#6 EXOD EXOD +22.08%
#7 Backpack Backpack +22.06%
#8 The Black Bull The Black Bull +21.96%
#9 GALA GALA +21.77%
#10 Velvet Velvet +21.75%
Coin of the day
Zora Zora
設定
言語
日本
通貨
USD
テーマ
Orexo AB Orexo AB

Orexo AB

ORX
株式のランク #24896
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
株価
$1.58
時価総額
$55.40M
変化（1日）
0.71%
変化（1年）
-28.43%
国
SE
取引 Orexo AB (ORX)

カテゴリー

Healthcare
Orexo AB（ORX）の利益
2026 時点の利益 TTM: 0
Orexo AB の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Orexo AB の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK